Style | Citing Format |
---|---|
MLA | Kiaie N, et al.. "Mesenchymal Stem Cell-Derived Exosomes for Covid-19 Therapy, Preclinical and Clinical Evidence." International Journal of Stem Cells, vol. 14, no. 3, 2021, pp. 252-261. |
APA | Kiaie N, Ghanavati SPM, Miremadi SS, Hadipour A, Aghdam RM (2021). Mesenchymal Stem Cell-Derived Exosomes for Covid-19 Therapy, Preclinical and Clinical Evidence. International Journal of Stem Cells, 14(3), 252-261. |
Chicago | Kiaie N, Ghanavati SPM, Miremadi SS, Hadipour A, Aghdam RM. "Mesenchymal Stem Cell-Derived Exosomes for Covid-19 Therapy, Preclinical and Clinical Evidence." International Journal of Stem Cells 14, no. 3 (2021): 252-261. |
Harvard | Kiaie N et al. (2021) 'Mesenchymal Stem Cell-Derived Exosomes for Covid-19 Therapy, Preclinical and Clinical Evidence', International Journal of Stem Cells, 14(3), pp. 252-261. |
Vancouver | Kiaie N, Ghanavati SPM, Miremadi SS, Hadipour A, Aghdam RM. Mesenchymal Stem Cell-Derived Exosomes for Covid-19 Therapy, Preclinical and Clinical Evidence. International Journal of Stem Cells. 2021;14(3):252-261. |
BibTex | @article{ author = {Kiaie N and Ghanavati SPM and Miremadi SS and Hadipour A and Aghdam RM}, title = {Mesenchymal Stem Cell-Derived Exosomes for Covid-19 Therapy, Preclinical and Clinical Evidence}, journal = {International Journal of Stem Cells}, volume = {14}, number = {3}, pages = {252-261}, year = {2021} } |
RIS | TY - JOUR AU - Kiaie N AU - Ghanavati SPM AU - Miremadi SS AU - Hadipour A AU - Aghdam RM TI - Mesenchymal Stem Cell-Derived Exosomes for Covid-19 Therapy, Preclinical and Clinical Evidence JO - International Journal of Stem Cells VL - 14 IS - 3 SP - 252 EP - 261 PY - 2021 ER - |